EMA/CHMP January meeting highlights

EMA/CHMP January meeting highlights


There were a number of positive, and negative, opinions issued on January 24, following the monthly meeting…

AB ScienceAdempasBayerBemfolaDainippon Sumitomo PharmaEuropeFinox BiotechHemoprostolLatudaLinepharmaMasivieraNerventraNovartisPTC TherapeuticsReasanzRegulationTakeda PharmaceuticalsTeva Pharmaceutical IndustriesTranslarna

Report: Latuda has greatest commercial potential among new agents entering the bipolar drug market

Report: Latuda has greatest commercial potential among new agents entering the bipolar drug market


Dainippon Sumitomo Pharma/Sunovion/Takeda Pharmaceutical’s atypical antipsychotic Latuda (lurasidone)…

Dainippon Sumitomo PharmaGlobalLatudaMarkets & MarketingNeurologicalPharmaceuticalTakeda Pharmaceuticals

Takeda gains first European approval for lurasidone


Japan's largest drugmaker Takeda Pharma (TYO: 4502) says it has been granted approval by Switzerland's…

Dainippon Sumitomo PharmaEuropeLatudalurasidoneNeurologicalPharmaceuticalRegulationTakeda Pharmaceuticals

Top-line financials for Japanese drug majors


Among a flurry of first-quarter fiscal 2013/14 financial results released by Japanese drug majors, the…

Dainippon Sumitomo PharmaEisaiFinancialMitsubishi TanabePharmaceuticalTakeda Pharmaceuticals

Top-line financial results from Japanese drug majors


Among a batch of Japanese drug majors presenting fiscal year 2013 (ended April 2013) financial results,…

Dainippon Sumitomo PharmaFinancialMitsubishi TanabePharmaceuticalShionogiTakeda Pharmaceuticals

Japan's drug majors post mixed financial results


Japan's leading drugmakers rolled out financial results for the first fiscal quarter of 2013, ended June…

Daiichi SankyoDainippon Sumitomo PharmaFinancialKyowa Hakko KirinPharmaceuticalTakeda Pharmaceuticals

Takeda links with Dainippon Sumitomo on two licensing deals; makes European management appointments


Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) has entered into a licensing accord with Takeda…

Antibiotics and Infectious diseasesAsia-PacificceftarolineDainippon Sumitomo PharmaEuropeLicensinglurasidoneManagementNeurologicalPharmaceuticalTakeda Pharmaceuticals



Back to top